As mentioned above, immunohistochemically, schwannomatous areas are strongly positive for S100 and SOX10, whereas the neurofibroma component expresses S100, SOX10, CD34, EMA, and GLUT-1 (Figure 6). The gene discussed is SLC2A1; the disease is neurofibroma.